Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    86,825.95
    -1,134.38 (-1.29%)
     
  • CMC Crypto 200

    1,328.01
    -68.52 (-4.91%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Stocks in play: Abattis Bioceuticals Corp.

Announced the company and its wholly-owned subsidiary, Vergence Naturals Ltd. have launched their “Live. Love. Life. Naturally!” marketing campaign to build awareness for their naturally inspired health and beauty brands for the conventional and cannabinoid-enhanced markets. The campaign is designed to promote the products and services of Vergence and the Company’s other affiliates. “We are very pleased with the consistent progress being made through our marketing and distribution arm, Vergence,” stated Rob Abenante, President and CEO of Abattis. “With the appointment of Dr. Brazos Minshew as Head of the Company’s Medical Advisory Board and President of Vergence’s Corporate Advisory Board, we look forward to the development of new formulations and innovative natural products for the conventional and cannabinoid-enhanced markets,” added Mr. Abenante. Abattis Bioceuticals Corp. shares ATT:CNX are trading off 2.44 percent at $0.20.